Internal Medicine, Gastroenterology · Bradenton, FL
NPI
1316977499
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4502 Cortez Rd W Ste 204
Bradenton, FL, 34210
Phone (941) 761-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,358 services
Medicare patients, 2024
193
Average age 75
Drug cost, 2024
$1.6M
1,108 prescriptions
Company payments, 2025
$1,904
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rimantas Zalepuga was code 88305 (surgical pathology examination), 683 times for 100 patients. In total Rimantas Zalepuga billed 1,358 services in 25 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 683 | 100 | $28.45 | $19K |
| 99214 Office E&M - Established | Office | 206 | 103 | $99.33 | $20K |
| 88312 Surgical Pathology Examination | Office | 122 | 35 | $69.46 | $8,474 |
| 45380 Lower GI Endoscopy - Other | Facility | 77 | 77 | $130.23 | $10K |
| 43239 Upper GI Endoscopy | Facility | 64 | 62 | $83.18 | $5,324 |
| 88313 Surgical Pathology Examination | Office | 55 | 35 | $56.99 | $3,134 |
| 99215 Office E&M - Established | Office | 35 | 24 | $146.63 | $5,132 |
| 45385 Colonoscopy - Lesion Removal | Facility | 29 | 28 | $209.31 | $6,070 |
| 45381 Lower GI Endoscopy - Other | Facility | 24 | 23 | $15.46 | $371 |
| 99204 Office E&M - New | Office | 19 | 19 | $106.81 | $2,029 |
| 99205 Office E&M - New | Office | 14 | 14 | $171.78 | $2,405 |
By year: 2022 $104K for 1,355 services; 2023 $109K for 1,360 services; 2024 $87K for 1,358 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 683 | 100 | $28.45 | $19K |
| 88312 Surgical Pathology Examination | 122 | 35 | $69.46 | $8,474 |
| 88313 Surgical Pathology Examination | 55 | 35 | $56.99 | $3,134 |
Medicare prescription drug claims, 2024
In 2024, the drug Rimantas Zalepuga prescribed most often to Medicare patients was Omeprazole, with 218 prescriptions and refills. In total Rimantas Zalepuga wrote 1,108 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 218 | 600 | 106 | $4,078 |
| Pantoprazole Sodium Generic | 148 | 374 | 81 | $2,468 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 60 | 60 | 60 | $1,293 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 58 | 58 | 58 | $880 |
| Creon Lipase/Protease/Amylase | 54 | 135 | 25 | $479K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 50 | 50 | 49 | $891 |
| Ursodiol Generic | 49 | 87 | 11 | $12K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 48 | 48 | 48 | $3,079 |
| Linzess Linaclotide | 42 | 96 | 20 | $51K |
| Sucraid Sacrosidase | 40 | 40 | 11 | $564K |
| Famotidine Generic | 37 | 100 | 21 | $508 |
| Movantik Naloxegol Oxalate | 28 | 56 | 14 | $23K |
| Budesonide Dr Budesonide | 24 | 49 | Under 11 | $4,457 |
| Zenpep Lipase/Protease/Amylase | 22 | 46 | 11 | $192K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 16 | 16 | 16 | $2,617 |
Brand drugs: 323 claims; generic drugs: 785 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rimantas Zalepuga $1,904 ($1,904 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $584.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $584 |
| QOL Medical, LLC | 10 | $388 |
| Madrigal Pharmaceuticals MDGL | 4 | $260 |
| Aimmune Therapeutics, Inc. | 10 | $185 |
| Gilead Sciences, Inc. GILD | 1 | $125 |
| Valencia Technologies Corporation | 1 | $78.32 |
| Intra-Sana Laboratories | 3 | $72.36 |
| Ardelyx, Inc. ARDX | 3 | $55.27 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $45.64 |
| Janssen Biotech, Inc. JNJ | 1 | $31.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.